A5028802408- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- COVID-19 epidemiological studies
- Respiratory viral infections research
- Data-Driven Disease Surveillance
European University at Saint Petersburg
2021-2022
Abstract Geographical variation in severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) spread requires seroprevalence studies based on local tests, but robust validation is needed. We summarize an evaluation of antibody tests used a serological study SARS‐CoV‐2 Saint Petersburg, Russia. validated three different assays: chemiluminescent microparticle immunoassay (CMIA) Abbott Architect immunoglobulin G (IgG), enzyme linked immunosorbent assay (ELISA) CoronaPass total antibodies...
Background The COVID-19 pandemic in Russia has already resulted 500,000 excess deaths, with more than 5.6 million cases registered officially by July 2021. Surveillance based on case reporting become the core monitoring method country and globally. However, population-based seroprevalence studies may provide an unbiased estimate of actual disease spread and, combination multiple surveillance tools, help to define course. This study summarises results from four consecutive serological surveys...
Background The COVID-19 pandemic in Russia has already resulted 500,000 excess deaths, with more than 5.6 million cases registered officially by July 2021. Surveillance based on case reporting become the core monitoring method country and globally. However, population-based seroprevalence studies may provide an unbiased estimate of actual disease spread and, combination multiple surveillance tools, help to define course. This study summarises results from four consecutive serological surveys...
Background An evident geographical variation in the SARS-CoV-2 spread requires seroprevalence studies based on local tests with robust validation against already available antibody and neutralization assays. This report summarizes evaluation of used representative population-based serological study Saint Petersburg, Russia. Methods We three different throughout study: chemiluminescent microparticle immunoassay (CMIA) Abbott Architect IgG, Enzyme-linked immunosorbent assay (ELISA) CoronaPass...